Tuesday, 24 December 2013
Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020
Biomarker is a technique to state the biological condition of individual. It has varied application in numerous fields like Disease Diagnosis, Drug Discovery, Drug Formulation, Forensic Applications, are Risk Assessment, Molecular Diagnostics etc
Rising innovation couples with huge strides in technology will only make biomarker’s market grow. A recent report by AMR analyst has estimated that market growth of Biomarker will reach $30.6 billion by 202 at a GAGR of 16%. In the area of disease diagnosis, biomarker is expected to reach $6.1 billion by the end of 2020. Even, Forensic and Molecular Diagnostic biomarker market is poised to grow with a rate of 17.6% during from 2013-2020.
Because biomarkers can detect deadly diseases at an early stage of life their popularity is increasing. It also studies Genomics and Proteomics pattern of a person, which will take it to a new tangent.
Applications, Services and types forms its market where application market is segmented as Risk Assessment, Molecular Diagnostics etc
A growth of 20% between 2013 and 2020 is estimated for Asia Pacific region.
Siemens Healthcare (Germany), Thermo Fisher Scientific, Inc. (U.S.), G.E. Healthcare Inc. (U.K) and Abbott Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Roche Diagnostic Limited (Switzerland) are significant companies that will play major role in this field.